Abstract:The mechanistic target of rapamycin complex 1 (mTORC1) is an important intracellular energy sensor that regulates protein synthesis through its downstream signaling components the S6‐kinase and the ribosomal S6 protein. Recently, our laboratory has demonstrated a critical role of the mTORC1 signaling pathway in the cardiovascular regulation with implications for obesity and hypertension. In this study, we tested the hypothesis that the mTORC1 signaling pathway in the vasculature is involved in the regulation of vascular endothelial function and that dysregulation of this pathway contributes to the cardiovascular disorders associated with obesity. We began by assessing the effects of activating mTORC1 signaling in cultured mouse lung endothelial cells (MLECs) using leucine (10 mM; 16hrs) or a constitutively active S6‐kinase adenoviral construct (Ad‐S6KCA; 48hrs). Activated mTORC1 signaling was confirmed by the increased phosphorylated levels of the ribosomal S6 protein (2–4 fold; p<0.05). Increasing mTORC1 signaling elevated mRNA expression of oxidative stress markers (NOX1 and NOX2; 1.5–5 fold; p<0.05), decreased mRNA expression of superoxide dismutase 2 (0.5 fold; p<0.05) and increased reactive oxygen species (ROS) generation (via dihydroethidium staining; 1.5 fold; p<0.05) in MLECs demonstrating a pro‐oxidant gene environment evoked by activation of mTORC1 signaling. Blockade of the IKKβ subunit of the NFκB transcriptional complex (BMS‐345541; 300nM) prevented mTORC1 signaling induced ROS generation in MLECs demonstrating a critical role of NFκB signaling in the cellular response to mTORC1 activation. Next, we used leucine and Ad‐S6KCA to test the consequence of enhancing mTORC1 signaling on endothelial function in aortic rings isolated from wildtype mice. Both leucine and an adenovirus expressing a constitutively active form of S6K (Ad‐S6KCA) impaired endothelial dependent acetylcholine‐induced relaxation (~10–15%; p<0.05) without changing endothelial‐independent relaxation responses evoked by sodium nitroprusside indicating endothelial but not smooth muscle dysfunction in response to increased mTORC1 signaling. Blockade of mTORC1 signaling using a dominant negative S6K adenoviral construct (Ad‐S6KDN) as well as inhibition of ROS signaling by Tempol (non‐specific free radical scavenger) ameliorated mTORC1‐induced endothelial dysfunction (p<0.05). To determine the involvement of mTORC1 signaling in the endothelial dysfunction associated with obesity, we utilized diet‐induced obese mice that display vascular endothelial dysfunction as compared to lean controls. Obese mice exhibited increased mTORC1 signaling in the aorta and mesenteric artery indicated by the elevated phosphorylated levels of the ribosomal S6 protein (1.5–3 fold; p<0.05) and this was associated with increases in NOX2 expression (1.5 fold; p<0.05) further indicating ROS signaling in the vascular pathology associated with obesity. We conclude that mTORC1 signaling is a novel regulator of vascular endothelial function through its effects on the NFκB complex and ROS signaling. Our data also indicate that dysregulation of the mTORC1 signaling pathway may be involved in the endothelial dysfunction associated with obesity.This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.

Mtorc1 Signaling is Required for Leucine to Induce Endothelial Dysfunction in the Mouse Aorta

Mtorc1 Signaling Regulates Vascular Endothelial Function Via Reactive Oxygen Species and NFκB Signaling

Abstract 080: Mtorc1 As a Novel Regulator of Vascular Endothelial Function in Obese Mice and Humans

Vascular Effects of Disrupting Endothelial Mtorc1 Signaling in Obesity

Endothelial Mtorc1 Signaling is Required for Vascular Endothelial Function

Mechanistic Target Of Rapamycin Complex 1 Signaling Modulates Vascular Endothelial Function Through Reactive Oxygen Species

Mtorc1 (mechanistic Target of Rapamycin Complex 1) Signaling in Endothelial and Smooth Muscle Cells is Required for Vascular Function.

Abstract P209: Mechanistic Target of Rapamycin Complex 1 (mtorc1) Signaling Generates Reactive Oxygen Species in Mouse Endothelial Cells Via NFkB Signaling

Abstract 067: Endothelial Mtorc1 Signaling Regulates Vascular Function and Mediates Angiotensin II Actions

Endothelial Leptin Receptor Deletion Promotes Cardiac Autophagy and Angiogenesis Following Pressure Overload by Suppressing Akt/mTOR Signaling

Activating transcription factor 4-dependent hsa-miR-663a transcription mediates mTORC1/p70S6K1 signaling underleucine deprivation.

Activating transcription factor 4-dependent hsa-miR-663a transcription mediates mTORC1/p70S6K1 signaling underleucine deprivation

Endothelial AMPK activation induces mitochondrial biogenesis and stress adaptation via eNOS-dependent mTORC1 signaling

mTORC1 in energy expenditure: consequences for obesity

Alterations to Mtorc1 Signaling in the Skeletal Muscle Differentially Affect Whole-Body Metabolism.

Amino Acid–Induced Activation of mTORC1 in Rat Liver Is Attenuated by Short-Term Consumption of a High-Fat Diet

Hypothalamic mTORC1 signaling controls sympathetic nerve activity and arterial pressure and mediates leptin effects.

Upregulation of Amino Acid Transporter Expression Induced by L-leucine Availability in L6 Myotubes is Associated with ATF4 Signaling Through Mtorc1-Dependent Mechanism.

Regulatory role of mammalian target of rapamycin signaling in exosome secretion and osteogenic changes in smooth muscle cells lacking acid ceramidase gene

Activation Of Mtor Modulates Srebp-2 To Induce Foam Cell Formation Through Increased Retinoblastoma Protein Phosphorylation

Identification of a leucine-mediated threshold effect governing macrophage mTOR signalling and cardiovascular risk